Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vidya Mave

Showing results (121-130 of 148) with videos related to

Pageof 15
Sort By:
The New England Journal of Medicine|October 3, 2019
Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum WomenAmita Gupta, Grace Montepiedra, Lisa Aaron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2019
Subtherapeutic Rifampicin Concentration Is Associated With Unfavorable Tuberculosis Treatment OutcomesGeetha Ramachandran, Padmapriyadarshini Chandrasekaran, Sanjay Gaikwad, et al.
The European Respiratory Journal|October 29, 2021
Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation studyAkshay N Gupte, Pavan Kumar, Mariana Araújo-Pereira, et al.
Frontiers in Immunology|June 27, 2022
Immunologic Biomarkers in Peripheral Blood of Persons With Tuberculosis and Advanced HIVArtur T L Queiroz, Mariana Araújo-Pereira, Beatriz Barreto-Duarte, et al.
Plos One|July 19, 2019
Infection free "resisters" among household contacts of adult pulmonary tuberculosisVidya Mave, Padmapriyadarshini Chandrasekaran, Amol Chavan, et al.
HIV Medicine|November 24, 2021
Weight changes, metabolic syndrome and all-cause mortality among Asian adults living with HIVWin Min Han, Matthew G Law, Jun Yong Choi, et al.
Trials|April 21, 2018
Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trialChishala Chabala, Anna Turkova, Margaret J Thomason, et al.
Lancet (London, England)|March 31, 2016
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trialMina C Hosseinipour, Gregory P Bisson, Sachiko Miyahara, et al.
Plos One|May 24, 2019
Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPDAkshay N Gupte, Mandar Paradkar, Sriram Selvaraju, et al.
The European Respiratory Journal|August 10, 2021
Host lipidome and tuberculosis treatment failureRupak Shivakoti, John W Newman, Luke Elizabeth Hanna, et al.
Pageof 15

Showing results (121-130 of 148) with videos related to

Sort By:
Pageof 15
The New England Journal of Medicine|October 3, 2019
Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum WomenAmita Gupta, Grace Montepiedra, Lisa Aaron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2019
Subtherapeutic Rifampicin Concentration Is Associated With Unfavorable Tuberculosis Treatment OutcomesGeetha Ramachandran, Padmapriyadarshini Chandrasekaran, Sanjay Gaikwad, et al.
The European Respiratory Journal|October 29, 2021
Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation studyAkshay N Gupte, Pavan Kumar, Mariana Araújo-Pereira, et al.
Frontiers in Immunology|June 27, 2022
Immunologic Biomarkers in Peripheral Blood of Persons With Tuberculosis and Advanced HIVArtur T L Queiroz, Mariana Araújo-Pereira, Beatriz Barreto-Duarte, et al.
Plos One|July 19, 2019
Infection free "resisters" among household contacts of adult pulmonary tuberculosisVidya Mave, Padmapriyadarshini Chandrasekaran, Amol Chavan, et al.
HIV Medicine|November 24, 2021
Weight changes, metabolic syndrome and all-cause mortality among Asian adults living with HIVWin Min Han, Matthew G Law, Jun Yong Choi, et al.
Trials|April 21, 2018
Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trialChishala Chabala, Anna Turkova, Margaret J Thomason, et al.
Lancet (London, England)|March 31, 2016
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trialMina C Hosseinipour, Gregory P Bisson, Sachiko Miyahara, et al.
Plos One|May 24, 2019
Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPDAkshay N Gupte, Mandar Paradkar, Sriram Selvaraju, et al.
The European Respiratory Journal|August 10, 2021
Host lipidome and tuberculosis treatment failureRupak Shivakoti, John W Newman, Luke Elizabeth Hanna, et al.
Pageof 15